Refining the role of antiplatelet therapy in medically managed patients with acute coronary syndrome

American Journal of Cardiology

Volumn 111, Issue 3, 2013, Pages 439-444

  Boden, William E ^a   Lansky, Alexandra ^b   Angiolillo, Dominick J ^c  

^a ALBANY MEDICAL COLLEGE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; TICAGRELOR;

ACUTE CORONARY SYNDROME; AGE; ANTICOAGULANT THERAPY; ARTICLE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DUAL ANTIPLATELET THERAPY; FRAIL ELDERLY; HIGH RISK PATIENT; HUMAN; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; UNSTABLE ANGINA PECTORIS;

EID: 84872316398     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.10.018     Document Type: Review

References (47)

1. G. Montalescot, S.D. Wiviott, E. Braunwald, S.A. Murphy, C.M. Gibson, C.H. McCabe, and E.M. Antman Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial Lancet 373 2009 723 731
2. D.J. Angiolillo, E.R. Bates, and T.A. Bass Clinical profile of prasugrel, a novel thienopyridine Am Heart J 156 2008 S16 S22
3. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, and E.M. Antman Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
4. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington, A. Freij, and M. Thorsen Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
5. B. Lombo, and J.G. Diez Ticagrelor: the evidence for its clinical potential as an oral antiplatelet treatment for the reduction of major adverse cardiac events in patients with acute coronary syndromes Core Evid 6 2011 31 42
6. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M.S. Uva, R.F. Storey, W. Wijns, D. Zahger, J.J. Bax, A. Auricchio, H. Baumgartner, C. Ceconi, V. Dean, C. Deaton, R. Fagard, C. Funck-Brentano, D. Hasdai, A. Hoes, J. Knuuti, P. Kolh, T. McDonagh, C. Moulin, D. Poldermans, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, A. Torbicki, A. Vahanian, S. Windecker, S. Achenbach, L. Badimon, M. Bertrand, H.E. Botker, J.P. Collet, F. Crea, N. Danchin, E. Falk, J. Goudevenos, D. Gulba, R. Hambrecht, J. Herrmann, A. Kastrati, K. Kjeldsen, S.D. Kristensen, P. Lancellotti, J. Mehilli, B. Merkely, G. Montalescot, F.J. Neumann, L. Neyses, J. Perk, M. Roffi, F. Romeo, M. Ruda, E. Swahn, M. Valgimigli, C.J. Vrints, and P. Widimsky ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes (ACS) in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
7. G.N. Levine, E.R. Bates, J.C. Blankenship, S.R. Bailey, J.A. Bittl, B. Cercek, C.E. Chambers, S.G. Ellis, R.A. Guyton, S.M. Hollenberg, U.N. Khot, R.A. Lange, L. Mauri, R. Mehran, I.D. Moussa, D. Mukherjee, B.K. Nallamothu, and H.H. Ting 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions Circulation 124 2011 e574 e651
8. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, D. Taggart, A. Vahanian, A. Auricchio, J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, B.A. Popescu, Z. Reiner, U. Sechtem, P.A. Sirnes, M. Tendera, P.E. Vardas, P. Widimsky, O. Alfieri, J. Dunning, S. Elia, P. Kappetein, U. Lockowandt, G. Sarris, P. Vouhe, L. von Segesser, S. Agewall, A. Aladashvili, D. Alexopoulos, M.J. Antunes, E. Atalar, A. Brutel de la Riviere, A. Doganov, J. Eha, J. Fajadet, R. Ferreira, J. Garot, J. Halcox, Y. Hasin, S. Janssens, K. Kervinen, G. Laufer, V. Legrand, S.A. Nashef, F.J. Neumann, K. Niemela, P. Nihoyannopoulos, M. Noc, J.J. Piek, J. Pirk, Y. Rozenman, M. Sabate, R. Starc, M. Thielmann, D.J. Wheatley, S. Windecker, and M. Zembala Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
9. H. Jneid, J.L. Anderson, R.S. Wright, C.D. Adams, C.R. Bridges, D.E. Casey Jr., S.M. Ettinger, F.M. Fesmire, T.G. Ganiats, A.M. Lincoff, E.D. Peterson, G.J. Philippides, P. Theroux, N.K. Wenger, and J.P. Zidar 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 60 2012 645 681
10. P.P. Dobesh Clopidogrel versus prasugrel: times are changing, but not for everyone Pharmacotherapy 29 2009 1393 1396
11. M.Y. Chan, K.W. Mahaffey, L.J. Sun, K.S. Pieper, H.D. White, P.E. Aylward, J.J. Ferguson, R.M. Califf, and M.T. Roe Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease JACC Cardiovasc Interv 1 2008 369 378
12. S.C. Smith Jr., E.J. Benjamin, R.O. Bonow, L.T. Braun, M.A. Creager, B.A. Franklin, R.J. Gibbons, S.M. Grundy, L.F. Hiratzka, D.W. Jones, D.M. Lloyd-Jones, M. Minissian, L. Mosca, E.D. Peterson, R.L. Sacco, J. Spertus, J.H. Stein, and K.A. Taubert AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation Circulation 124 2011 2458 2473
13. K.A. Fox, S.R. Mehta, R. Peters, F. Zhao, N. Lakkis, B.J. Gersh, and S. Yusuf Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events (CURE) trial Circulation 110 2004 1202 1208
14. S.K. James, M.T. Roe, C.P. Cannon, J.H. Cornel, J. Horrow, S. Husted, H. Katus, J. Morais, P.G. Steg, R.F. Storey, S. Stevens, L. Wallentin, and R.A. Harrington Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised Platelet Inhibition and Patient Outcomes (PLATO) trial BMJ 342 2011 d3527
15. 12 receptor inhibitors: integrating ticagrelor into the management of acute coronary syndrome Ann Pharmacother 45 2011 1151 1156
16. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
17. C.T. Chin, M.T. Roe, K.A. Fox, D. Prabhakaran, D.A. Marshall, H. Petitjean, Y. Lokhnygina, E. Brown, P.W. Armstrong, H.D. White, and E.M. Ohman Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial Am Heart J 160 2010 16 22
18. M.T. Roe, P.W. Armstrong, K.A. Fox, H.D. White, D. Prabhakaran, S.G. Goodman, J.H. Cornel, D.L. Bhatt, P. Clemmensen, F. Martinez, D. Ardissino, J.C. Nicolau, W.E. Boden, P.A. Gurbel, W. Ruzyllo, A.J. Dalby, D.K. McGuire, J.L. Leiva-Pons, A. Parkhomenko, S. Gottlieb, G.O. Topacio, C. Hamm, G. Pavlides, A.R. Goudev, A. Oto, C.D. Tseng, B. Merkely, V. Gasparovic, R. Corbalan, M. Cinteza, R.C. McLendon, K.J. Winters, E.B. Brown, Y. Lokhnygina, P.E. Aylward, K. Huber, J.S. Hochman, and E.M. Ohman Prasugrel versus clopidogrel for acute coronary syndromes without revascularization N Engl J Med 367 2012 1297 1309
19. J. Menzin, G. Wygant, O. Hauch, J. Jackel, and M. Friedman One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database Curr Med Res Opin 24 2008 461 468
20. R. Holubkov, W.K. Laskey, A. Haviland, J.C. Slater, M.G. Bourassa, H.A. Vlachos, H.A. Cohen, D.O. Williams, S.F. Kelsey, and K.M. Detre Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry Am Heart J 144 2002 826 833
21. V.M. Legrand, P.W. Serruys, F. Unger, B.A. van Hout, M.C. Vrolix, G.M. Fransen, T.T. Nielsen, P.K. Paulsen, R.S. Gomes, J.M. de Queiroz e Melo, J.P. Neves, W. Lindeboom, and B. Backx Three-year outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease Circulation 109 2004 1114 1120
22. Z. Zhang, J.A. Spertus, E.M. Mahoney, J. Booth, F. Nugara, R.H. Stables, and W.S. Weintraub The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the Stent or Surgery (SoS) trial Am Heart J 150 2005 175 181
23. G.W. Stone, A. Maehara, A.J. Lansky, B. de Bruyne, E. Cristea, G.S. Mintz, R. Mehran, J. McPherson, N. Farhat, S.P. Marso, H. Parise, B. Templin, R. White, Z. Zhang, P.W. Serruys, and PROSPECT Investigators A prospective natural-history study of coronary atherosclerosis N Engl J Med 364 2011 226 235
24. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. Lopez-Sendon, G. Montalescot, P. Theroux, M.J. Claeys, F. Cools, K.A. Hill, A.M. Skene, C.H. McCabe, and E. Braunwald Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med 352 2005 1179 1189
25. F.G. Kushner, M. Hand, S.C. Smith Jr., S.B. King III, J.L. Anderson, E.M. Antman, S.R. Bailey, E.R. Bates, J.C. Blankenship, D.E. Casey Jr., L.A. Green, J.S. Hochman, A.K. Jacobs, H.M. Krumholz, D.A. Morrison, J.P. Ornato, D.L. Pearle, E.D. Peterson, M.A. Sloan, P.L. Whitlow, and D.O. Williams 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 2009 2271 2306
26. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, T.A. Bass, and M.A. Costa Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
27. J.D. Snoep, M.M. Hovens, J.C. Eikenboom, J.G. van der Bom, J.W. Jukema, and M.V. Huisman Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis Am Heart J 154 2007 221 231
28. H. Neubauer, A.F. Kaiser, H.G. Endres, J.C. Kruger, A. Engelhardt, S. Lask, F. Pepinghege, A. Kusber, and A. Mugge Tailored antiplatelet therapy can overcome clopidogrel and aspirin resistance - the Bochum Clopidogrel and Aspirin Plan (BOCLA-Plan) to improve antiplatelet therapy BMC Med 9 2011 3
29. S. Azmoon, and D.J. Angiolillo Switching antiplatelet regimens: alternatives to clopidogrel in patients with acute coronary syndrome undergoing PCI: a review of the literature and practical considerations for the interventional cardiologist Catheter Cardiovasc Interv 2012 May 14 [Epub ahead of print]
30. D. Alexopoulos, G. Dimitropoulos, P. Davlouros, I. Xanthopoulou, G. Kassimis, E.F. Stavrou, G. Hahalis, and A. Athanassiadou Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping JACC Cardiovasc Interv 4 2011 403 410
31. D.J. Angiolillo, J.J. Badimon, J.F. Saucedo, A.L. Frelinger, A.D. Michelson, J.A. Jakubowski, B. Zhu, C.K. Ojeh, B.A. Baker, and M.B. Effron A pharmacodynamic comparison of prasugrel vs. high-dose clopidogrel in patients with type 2 diabetes mellitus and coronary artery disease: results of the Optimizing Anti-Platelet Therapy in Diabetes Mellitus (OPTIMUS)-3 Trial Eur Heart J 32 2011 838 846
32. R.R. Arora, and F. Rai Antiplatelet intervention in acute coronary syndrome Am J Ther 16 2009 e29 e40
33. M. Roffi, and E.J. Topol Percutaneous coronary intervention in diabetic patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 25 2004 190 198
34. V. Fuster, and M.E. Farkouh Acute coronary syndromes and diabetes mellitus: a winning ticket for prasugrel Circulation 118 2008 1607 1608
35. S. James, D.J. Angiolillo, J.H. Cornel, D. Erlinge, S. Husted, F. Kontny, J. Maya, J.C. Nicolau, J. Spinar, R.F. Storey, S.R. Stevens, and L. Wallentin Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the Platelet Inhibition and Patient Outcomes (PLATO) trial Eur Heart J 31 2010 3006 3016
36. S.D. Wiviott, E. Braunwald, D.J. Angiolillo, S. Meisel, A.J. Dalby, F.W. Verheugt, S.G. Goodman, R. Corbalan, D.A. Purdy, S.A. Murphy, C.H. McCabe, and E.M. Antman Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38 Circulation 118 2008 1626 1636
37. M. Cohen, and J.J. Ferguson Re-evaluating risk factors for periprocedural complications during percutaneous coronary intervention in patients with unstable angina/non-ST-elevation myocardial infarction: who may benefit from more intensive antiplatelet therapy? Curr Opin Cardiol 24 2009 88 94
38. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, J.W. Moses, H.D. White, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, P.E. Aylward, A.R. Cequier, H. Darius, W. Desmet, R. Ebrahimi, M. Hamon, L.H. Rasmussen, H.J. Rupprecht, J. Hoekstra, R. Mehran, E.M. Ohman, and ACUITY Investigators Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
39. K. Goto, A.J. Lansky, M. Fahy, E. Cristea, F. Feit, E.M. Ohman, H.D. White, K.P. Alexander, M.E. Bertrand, W. Desmet, M. Hamon, R. Mehran, and G.W. Stone Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy Circulation 121 2010 853 862
40. M.Y. Chan, R.C. Becker, R.A. Harrington, E.D. Peterson, P.W. Armstrong, H. White, K.A. Fox, E.M. Ohman, and M.T. Roe Noninvasive, medical management for non-ST-elevation acute coronary syndromes Am Heart J 155 2008 397 407
41. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr., C.B. Granger, M.D. Flather, A. Budaj, A. Quill, and J.M. Gore Decline in rates of death and heart failure in acute coronary syndromes 1999-2006 JAMA 297 2007 1892 1900
42. A. Neyou, E. Kline-Rogers, D.G. Montgomery, A. Cheng, A.K. Olomu, E.A. Jackson, J.B. Froehlich, and K.A. Eagle Two-year outcomes after inpatient revascularization versus non-revascularization in elderly patients (>75 years old) with acute coronary syndromes J Am Coll Cardiol 57 2011 E1053
43. E.A. Amsterdam, E.D. Peterson, F.S. Ou, L.K. Newby, C.V. Pollack Jr., W.B. Gibler, E.M. Ohman, and M.T. Roe Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: results from the CRUSADE quality improvement initiative Am Heart J 158 2009 748 754, e741
44. K.A. Eagle, B.K. Nallamothu, R.H. Mehta, C.B. Granger, P.G. Steg, F. Van de Werf, J. Lopez-Sendon, S.G. Goodman, A. Quill, and K.A. Fox Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go Eur Heart J 29 2008 609 617
45. C. Dib, E.B. Hanna, and M.S. Abu-Fadel A new era for antiplatelet therapy in patients with acute coronary syndrome Am J Med Sci 340 2010 407 411
46. K.P. Alexander, M.T. Roe, A.Y. Chen, B.L. Lytle, C.V. Pollack Jr., J.M. Foody, W.E. Boden, S.C. Smith Jr., W.B. Gibler, E.M. Ohman, and E.D. Peterson Evolution in cardiovascular care for elderly patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative J Am Coll Cardiol 46 2005 1479 1487
47. A. El-Menyar, M. Zubaid, K. Sulaiman, R. Singh, H. Al Thani, M. Akbar, B. Bulbanat, R. Al-Hamdan, W. Almahmmed, and J. Al Suwaidi In-hospital major clinical outcomes in patients with chronic renal insufficiency presenting with acute coronary syndrome: data from a registry of 8176 patients Mayo Clin Proc 85 2010 332 340